Skip to main content
NEPH logo

NEPH · Nephros Inc · Documents

Track NEPH — free
$2.79 -0.30 (-9.71%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Market Cap
$32.61M
Shares
10.87M
Volume · Nov 6 104.03K Avg daily vol (3M) 39.66K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $18.79M up 32.7% 10-K filed Mar 12, 2026 Quarterly report New FY2026 Q3 Revenue $5.62M up 18.0% 10-Q filed Nov 5, 2026 Latest results New Financial results 8-K filed Nov 5, 2026 Earnings call Q2 2026 earnings call Held Aug 6, 2026
2026
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $5.62M ▲ 18.0% Net income $512K ▲ 51.9% Diluted EPS $0.05 ▲ 66.7%
Oct 14
Proxy statement DEF 14A
Proxy statement

Nephros, Inc. will hold a virtual annual meeting on November 25, 2026, seeking election of Robert Banks and Joseph Harris, ratification of Baker Tilly US, LLP, and advisory votes on executive compensation and vote frequency.

Read from the first part of this long document
Oct 13
Current report 8-K
Shareholder director nominations, Other events

Nephros set Wednesday, November 25, 2026, at 11:00 a.m., Eastern Time for its virtual 2026 Annual Meeting, with September 30, 2026 as the record date. Stockholder proposals are due by close of business October 23, 2026; notice for other director nominees is due no later than October 23, 2026.

Aug 10
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $6.02M ▲ 36.2% Net income $1.2M ▲ 405.1% Diluted EPS $0.11 ▲ 450.0%
May 7
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $5.21M ▲ 6.9% Net income $140K ▼ 74.9% Diluted EPS $0.01 ▼ 80.0%
Mar 12
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $18.79M ▲ 32.7% Net income $1.19M ▲ 1513.5% Diluted EPS $0.11 ▲ 1000.0%
2025
Nov 6
Quarterly report 10-Q FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $4.76M ▲ 35.4% Net income $337K ▲ 84.2% Diluted EPS $0.03 ▲ 50.0%
Mar 24
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $14.16M ▼ 0.5% Net income $74K Diluted EPS $0.01
2024
Mar 15
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $14.24M ▲ 42.7% Net loss $1.58M Diluted EPS -$0.15
Showing 1–50 of 148 documents
Key facts CIK 1196298 CUSIP 640671400 13F (30d) 7 filings 7 filers Visit website Investor relations